1 - 25 of
123
results
for author:"Schneider C."
in Literature Citations
| RNA helicase Prp43 and its co-factor Pfa1 promote 20S to 18S rRNA processing catalyzed by the endonuclease Nob1. Pertschy B., Schneider C., Gnadig M., Schafer T., Tollervey D., Hurt E. J. Biol. Chem. 0:0-0(2009) · Mapped (6) |
| BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Saito M., Novak U., Piovan E., Basso K., Sumazin P., Schneider C., Crespo M., Shen Q., Bhagat G., Califano A. et al. Proc. Natl. Acad. Sci. U.S.A. 106:11294-11299(2009) · Mapped (14) |
| p65/RelA modulates BECN1 transcription and autophagy. Copetti T., Bertoli C., Dalla E., Demarchi F., Schneider C. Mol. Cell. Biol. 29:2594-2608(2009) · Mapped (10) |
| Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour. Vashist Y.K., Uzunoglu G., Cataldegirmen G., Kalinin V., Schurr P., Koenig A.M., Thieltges S., Zehler O., Schneider C., Izbicki J.R. et al. Histopathology 54:303-308(2009) · Mapped (4) |
| The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome. Schneider C., Leung E., Brown J., Tollervey D. Nucleic Acids Res. 37:1127-1140(2009) · Mapped (5) |
| An endoribonuclease functionally linked to perinuclear mRNP quality control associates with the nuclear pore complexes. Skruzny M., Schneider C., Racz A., Weng J., Tollervey D., Hurt E. PLoS Biol. 7:e8-e8(2009) · Mapped (15) |
| Epidermal growth factor receptor-related tumor markers and clinical outcomes with erlotinib in non-small cell lung cancer: an analysis of patients from german centers in the TRUST study. Schneider C.P., Heigener D., Schott-von-Romer K., Gutz S., Laack E., Digel W., Guschall W.R., Franke A., Bodenstein H., Schmidtgen C. et al. J Thorac Oncol 3:1446-1453(2008) · Mapped (23) |
| Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A. Bertoli C., Copetti T., Lam E.W., Demarchi F., Schneider C. Oncogene 28:721-733(2009) · Mapped (4) |
| Minor spliceosome components are predominantly localized in the nucleus. Pessa H.K., Will C.L., Meng X., Schneider C., Watkins N.J., Perala N., Nymark M., Turunen J.J., Luhrmann R., Frilander M.J. Proc. Natl. Acad. Sci. U.S.A. 105:8655-8660(2008) · Mapped (25) |
| Ccr4 alters cell size in yeast by modulating the timing of CLN1 and CLN2 expression. Manukyan A., Zhang J., Thippeswamy U., Yang J., Zavala N., Mudannayake M.P., Asmussen M., Schneider C., Schneider B.L. Genetics 179:345-357(2008) · Mapped (10) |
| Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease. Pfister R., Tan D., Thekkanal J., Erdmann E., Schneider C.A. Dtsch. Med. Wochenschr. 133:564-569(2008) · Mapped (2) |
| Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Lintas C., Sacco R., Garbett K., Mirnics K., Militerni R., Bravaccio C., Curatolo P., Manzi B., Schneider C., Melmed R. et al. Mol. Psychiatry 14:705-718(2009) · Mapped (2) |
| Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients. Vashist Y.K., Blessmann M., Trump F., Kalinin V., Kutup A., Schneider C., Gawad K., Kaifi J.T., Schmelzle R., Izbicki J.R. et al. J. Oral Pathol. Med. 37:480-484(2008) · Mapped (4) |
| Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium. Diedrichs H., Hagemeister J., Chi M., Boelck B., Muller-Ehmsen J., Schneider C.A. J. Int. Med. Res. 35:803-818(2007) · Mapped (12) |
| L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Kaifi J.T., Reichelt U., Quaas A., Schurr P.G., Wachowiak R., Yekebas E.F., Strate T., Schneider C., Pantel K., Schachner M. et al. Mod. Pathol. 20:1183-1190(2007) · Mapped (12) |
| The exosome subunit Rrp44 plays a direct role in RNA substrate recognition. Schneider C., Anderson J.T., Tollervey D. Mol. Cell 27:324-331(2007) · Mapped (15) |
| Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction. Chen F., Qian L., Yang Z.H., Huang Y., Ngo S.T., Ruan N.J., Wang J., Schneider C., Noakes P.G., Ding Y.Q. et al. Neuron 55:247-260(2007) · Mapped (40) |
| Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells. O'Connor J.C., Farach-Carson M.C., Schneider C.J., Carson D.D. Mol. Cancer Res. 5:585-603(2007) · Mapped (19) |
| Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARalpha. Yu Z., Schneider C., Boeglin W.E., Brash A.R. Lipids 42:491-497(2007) · Mapped (24) |
| Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. Sacco R., Papaleo V., Hager J., Rousseau F., Moessner R., Militerni R., Bravaccio C., Trillo S., Schneider C., Melmed R. et al. BMC Med. Genet. 8:11-11(2007) · Mapped (7) |
| HOXA1 gene variants influence head growth rates in humans. Muscarella L.A., Guarnieri V., Sacco R., Militerni R., Bravaccio C., Trillo S., Schneider C., Melmed R., Elia M., Mascia M.L. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B:388-390(2007) · Mapped (3) |
| A genetic variant that disrupts MET transcription is associated with autism. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R. et al. Proc. Natl. Acad. Sci. U.S.A. 103:16834-16839(2006) · UniProtKB (1) · Mapped (22) |
| Human and mouse eLOX3 have distinct substrate specificities: implications for their linkage with lipoxygenases in skin. Yu Z., Schneider C., Boeglin W.E., Brash A.R. Arch. Biochem. Biophys. 455:188-196(2006) · Mapped (9) |
| The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Rath G.M., Schneider C., Dedieu S., Rothhut B., Soula-Rothhut M., Ghoneim C., Sid B., Morjani H., El Btaouri H., Martiny L. Biochim. Biophys. Acta 1763:1125-1134(2006) · Mapped (6) |
| MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Monte M., Simonatto M., Peche L.Y., Bublik D.R., Gobessi S., Pierotti M.A., Rodolfo M., Schneider C. Proc. Natl. Acad. Sci. U.S.A. 103:11160-11165(2006) · Mapped (35) |
